
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285d-1]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
subpart 4--national institute of arthritis and musculoskeletal and skin 
                                diseases
 
Sec. 285d-1. National arthritis and musculoskeletal and skin 
        diseases program
        

(a) Plan to expand, intensify, and coordinate activities; submission; 
        periodic review and revision

    The Director of the Institute, with the advice of the Institute's 
advisory council, shall prepare and transmit to the Director of NIH a 
plan for a national arthritis and musculoskeletal and skin diseases 
program to expand, intensify, and coordinate the activities of the 
Institute respecting arthritis and musculoskeletal and skin diseases. 
The plan shall include such comments and recommendations as the Director 
of the Institute determines appropriate. The plan shall place particular 
emphasis upon expanding research into better understanding the causes 
and the development of effective treatments for arthritis affecting 
children. The Director of the Institute shall periodically review and 
revise such plan and shall transmit any revisions of such plan to the 
Director of NIH.

(b) Coordination of activities with other national research institutes; 
        minimum activities under program

    Activities under the national arthritis and musculoskeletal and skin 
diseases program shall be coordinated with the other national research 
institutes to the extent that such institutes have responsibilities 
respecting arthritis and musculoskeletal and skin diseases, and shall, 
at least, provide for--
        (1) investigation into the epidemiology, etiology, and 
    prevention of all forms of arthritis and musculoskeletal and skin 
    diseases, including sports-related disorders, primarily through the 
    support of basic research in such areas as immunology, genetics, 
    biochemistry, microbiology, physiology, bioengineering, and any 
    other scientific discipline which can contribute important knowledge 
    to the treatment and understanding of arthritis and musculoskeletal 
    and skin diseases;
        (2) research into the development, trial, and evaluation of 
    techniques, drugs, and devices used in the diagnosis, treatment, 
    including medical rehabilitation, and prevention of arthritis and 
    musculoskeletal and skin diseases;
        (3) research on the refinement, development, and evaluation of 
    technological devices that will replace or be a substitute for 
    damaged bone, muscle, and joints and other supporting structures;
        (4) the establishment of mechanisms to monitor the causes of 
    athletic injuries and identify ways of preventing such injuries on 
    scholastic athletic fields; and
        (5) research into the causes of arthritis affecting children and 
    the development, trial, and evaluation of techniques, drugs and 
    devices used in the diagnosis, treatment (including medical 
    rehabilitation), and prevention of arthritis in children.

(c) Program to be carried out in accordance with plan

    The Director of the Institute shall carry out the national arthritis 
and musculoskeletal and skin diseases program in accordance with the 
plan prepared under subsection (a) of this section and any revisions of 
such plan made under such subsection.

(July 1, 1944, ch. 373, title IV, Sec. 436, as added Pub. L. 99-158, 
Sec. 2, Nov. 20, 1985, 99 Stat. 848; amended Pub. L. 100-607, title I, 
Sec. 136, Nov. 4, 1988, 102 Stat. 3056; Pub. L. 103-43, title VII, 
Sec. 701(b), June 10, 1993, 107 Stat. 162.)


                               Amendments

    1993--Subsec. (a). Pub. L. 103-43, Sec. 701(b)(1), inserted after 
second sentence ``The plan shall place particular emphasis upon 
expanding research into better understanding the causes and the 
development of effective treatments for arthritis affecting children.''
    Subsec. (b)(5). Pub. L. 103-43, Sec. 701(b)(2), added par. (5).
    1988--Pub. L. 100-607 inserted ``and skin'' after 
``musculoskeletal'' in section catchline and wherever appearing in text.

                  Section Referred to in Other Sections

    This section is referred to in section 285d-7 of this title.
